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INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) envelope gly-
coprotein (Env) displays a key function in viral life cycle by medi-
ating the entry into host cells (1, 2). HIV-1 Env is synthesized as
a single polyprotein gp160 and subsequently cleaved to generate
gp120 and gp41. Env acts as a trimer composed of a heterodimer
of non-covalently linked gp120 and gp41. Gp120 is a surface pro-
tein of virions, and binds to receptor CD4 and coreceptor CCR5 or
CXCR4. Depending on the usage of CCR5 or CXCR4 for viral entry,
HIV-1 strains are categorized into R5-tropic or X4-tropic viruses,
respectively. Gp41 is a transmembrane protein harboring cytoplas-
mic tail (CT) region, and works for viral -host membrane fusion.
Accumulating evidence suggests that the number of Env trimers
required for viral entry is different among HIV-1 strains (3-5). Env
has a high capacity of mutation to escape from recognition by host
immune system, and is a highly diverse protein in HIV-1 proteins.
This high mutation rate/diversity of Env induces strain-specific
changes for viral fitness, neutralizing antibody resistance, and in-
hibitor sensitivity, and strongly affects viral phenotypes (6, 7).
HIV-1 virion assembly mainly proceeds by cooperation of four
major domains of Gag polyprotein, matrix (MA), capsid (CA), nu-
cleocapsid (NC), and p6. Gag-MA is associated with trafficking of
the Gag polyprotein to plasma membrane, main site for virion as-
sembly. Gag-CA induces Gag-Gag interaction to assemble viral
structural proteins. Gag-NC binds to viral genomic RNA, and Gag-
p6 is implicated in membrane fission of viral particles and host cells
(1, 8). It has been demonstrated that Gag-MA also functions for
virion- incorporation of Env through interaction with Env gp41
CT (1, 9). Recent study showed that Gag-MA mutations (62QR and
66SR) rescue defects in virion- incorporation of Env/viral replica-
tion caused by Gag-MA mutations or by gp41 CT deletion (10).
However, effects of these Gag-MA mutations on virion- incorpora-
tion of Env/viral replication were examined only for X4-tropic HIV-
1 clone NL4-3 but not for the others.
We have been working on construction and characterization of
rhesus macaque-tropic HIV-1 (HIV-1rmt) clones to establish HIV-
1/AIDS primate models that would greatly contribute to basic and
clinical studies. We have successfully generated HIV-1rmt clones
for the first time that overcome species-specific barriers imposed
by host restriction factors, APOBEC3 proteins, TRIM5 proteins,
and tetherin (11). Although R5-tropic HIV-1rmt is important for
clinical studies on AIDS due to its role in viral persistence and
transmission in individuals, our R5-tropic HIV-1rmt clone desig-
nated MN5/LSDQgtu (5gtu) grew more poorly than an X4-tropic
HIV-1rmt clone designated MN4/LSDQgtu (11, 12). In this study,
we investigated effects of Gag-MA mutations (62QR and 66SR)
described above on R5-tropic HIV-1rmt life cycle (single-cycle in-
fectivity, viron production, and multi -cycle replication). Our results
here show that the Gag-MA 66SR mutation positively acts on single-
cycle viral infectivity.
MATERIALS AND METHODS
Plasmid DNAs
Generation and characterization of HIV-1rmt clones MN4/
LSDQgtu (4gtu) and 5gtu (Fig. 1) have been previously described
(11, 12). Introduction of Gag-MA 62QR and 66SR into proviral
clones were carried out by the QuickChange site -directed mutage-
nesis kit (Agilent Technologies Inc.).
Cells, virus preparation, and reverse transcriptase (RT) assay
A reporter cell line TZM-bl carrying a luciferase gene driven by
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viral long-terminal repeat and a human 293T cell line (13) were
maintained in Eagle’s minimal essential containing 10% heat-
inactivated fetal bovine serum. A immortalized lymphocyte cell line
M1.3S from a rhesus macaque (14) was maintained in RPMI1640
medium containing 10% heat- inactivated fetal bovine serum and
50 units/ml of recombinant human interleukin-2 (Bio-Rad Labo-
ratories Inc.). Virus stocks for infection experiments were prepared
from 293T cells transfected with various proviral clones by the
calcium-phosphate co-precipitation method (15), and their virion-
associated RT activities were determined as previously described
(11, 16).
Viral infection experiments
Multi -cycle replication analysisM1.3S cells were infected by
virus samples with equal RT units, and virus growth was monitored
at intervals by RT activity in the culture supernatants. Single-cycle
infectivity analysisCulture supernatants were obtained from the
M1.3S infection experiment, and equal RT units (1104 to 2104)
of viruses for each sampling day were inoculated into TZM-bl cells
(5103). On day 1 post- infection, cell lysates were prepared for
luciferase assays (Promega Corporation). Significance relative to
5gtu was calculated by the Student t test.
Analysis of virion production
Proviral clones were transfected into 293T cells by the calcium-
phosphate co-precipitation method as above. Culture supernatants
were collected on day 2 post- transfection, and virion production
level was determined by RT assays. Significance relative to 5gtu
was calculated by the Student t test.
RESULTS AND DISCUSSION
Mature infectious HIV-1 virions are generated following appro-
priate assembly/cleavage of viral Env and Gag precursors (Fig. 2)
in the last viral replication phase. Gag-MA plays a pivotal role for
the virion- incorporation of Env, and mutations in the region greatly
influence the process. It has been reported that HIV-1 Gag-MA
62QR and 66SR mutations similarly restore defects in virion- in-
corporation of Env/viral replication displayed by Gag-MA mutant
viruses (10). However, introduction of 62QR or 66SR into a normal
wild- type clone did not affect much the viral growth ability (10).
Since these results were obtained from virological analysis of X4-
tropic HIV-1 NL4-3 clone, we examined the amino acid residues
at 62 and 66 sites of various R5-tropic viruses (AD8, JRFL, and
YU-2). Residue 62Q was completely conserved among these viral
clones including NL4-3, but residue 66A was found only for JRFL
clone (Fig. 3). We further investigated amino acid frequencies at
these sites within a large HIV-1 population by the HIV-1/SIVcpz
complete genomes (199 strains) in the HIV-1 sequence compen-
dium 2014 (Los Alamos National Laboratory ; http : //www.hiv.
lanl.gov). Again, 62Q was very highly conserved, but 66S was not
much shared by viruses (Table 1). It is well -established that inter-
action between Gag-MA and Env gp41 CT is critical for virion-
incorporation of Env and viral replication ability (1, 9, 10). We there-
fore compared amino acid sequences in gp41 CT region of various
HIV-1 clones (X4-tropic NL4-3, and R5-tropic SF162, AD8, JRFL,
and YU-2 clones). Amino acid sequences in the region were con-
siderably different, and particularly significant sequence character-
istics were not noted for NL4-3 clone (Fig. 4).
R5-tropic HIV-1rmt 5gtu was generated by modification of gag -
CA, vif , and vpu genes, and has an env gene derived from HIV-1
Figure 1 Proviral genome structure of R5- tropic HIV-1rmt MN5/LSDQgtu (5gtu). HIV-1 NL4-3 (15) (GenBank accession number AF324493),
SIVmac239 MA239 (19) (GenBank accession number M33262), HIV-1 SF162 (GenBank accession number M65024), and SIVgsn166 (GenBank
accession number AF468659) sequences are indicated by white, gray, stripe, and black areas, respectively. Arrows represent the sites of growth-
enhancing adaptive mutations (18). Clone 5gtu carries four single -amino acid mutations around the two gray areas in the Gag-CA region (11, 20).
Figure 2 Precursor structures of HIV-1 Env and Gag proteins. Upper : Env subunits gp120 and gp41 are presented. Gp41 cytoplasmic tail (CT)
is shown by gray area as indicated. Lower : Four domains and spacer peptide (SP) regions of Gag polyprotein are shown. Dotted area indicates
Gag-matrix (Gag-MA) region. CA, capsid ; NC, nucleocapsid.
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SF162 (Fig. 1). To examine effects of Gag-MA mutations on 5gtu,
we introduced 62QR and 66SR into 5gtu to construct HIV-1rmt
clones 62QR+5gtu and 66SR+5gtu, respectively. Viruses were pre-
pared from 293T cells transfected with proviral clones (5gtu, 62QR+
5gtu, and 66SR+5gtu), and inoculated into rhesus lymphocyte
M1.3S cells. As shown in Fig. 5, while 62QR+5gtu grew signifi-
cantly more poorly than 5gtu, 66SR+5gtu exhibited slightly more
retarded growth kinetics relative to 5gtu. To see if this result is
applicable to the other R5-tropic viruses, and to confirm a gener-
alization of above observation, we generated two other R5-tropic
HIV-1rmt clones carrying an env gene from a simian immunode-
ficiency virus/HIV-1 chimeric virus clone (SHIVAD8 - EH) (17) or
from an HIV-1 clinical isolate. We then performed the M1.3S in-
fection experiments as above. Introduction of 62QR into these two
viral clones eliminated the viral replication ability, but that of 66SR
did not show a significant effect on their growth potentials relative
to parental clones (data not shown). Totally, 62QR mutation was
detrimental to R5-tropic viruses but not 66SR. In agreement with
the previous data for X4-tropic NL4-3 (10), the 62QR mutation
severely impeded viral single-cycle infectivity of our there R5-
tropic viruses tested here for TZM-bl cells (data not shown). This
result is consistent with the conserved nature of Gag-MA 62Q in
Figure 3 Amino acid sequence alignment of Gag-MA proteins from various HIV-1 strains. Sequences were aligned by Genetyx Ver. 11. Gag
start residue M (Met) is removed from the sequences, and second residue G (Gly) is presented at amino acid position 1. Arrows show the amino
acid positions 62 and 66.
Table 1 Amino acid frequency at positions 62 and 66 in Gag-MAa
Positions Amino acid No. %
62 Q 197 99.0
H 1 0.5
K 1 0.5
66 S 69 34.7
A 101 50.8
T 26 13.1
D 1 0.5
N 1 0.5
Xb 1 0.5
a Data are from 199 sequences of HIV-1/SIVcpz complete genomes in
the HIV Sequence Compendium, 2014 (Los Alamos National Laboratory ;
http : //www.hiv.lanl.gov).
b Unidentified amino acid
Figure 4 Amino acid sequence alignment of gp41 CT from various HIV-1 strains. Sequences were aligned by Genetyx Ver. 11. The gp41 CT se-
quence of 5gtu is identical to that of HIV-1 SF162.
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an HIV-1 population (Fig. 3 and Table 1).
We noticed that 66SR+5gtu appeared to induce stronger cyto-
pathic effects than 5gtu despite their considerably similar growth
kinetics in M1.3S cells. To further examine biological properties
of 5gtu and 66SR+5gtu, we first determined multi -cycle growth
kinetics in M1.3S cells of three HIV-1rmt clones (X4-tropic 4gtu,
R5-tropic 5gtu, and R5-tropic 66SR+5gtu). Major difference be-
tween 4gtu and 5gtu is their env sequences : 4gtu env from HIV-1
NL4-3 and 5gtu env from SF162, respectively, and both have some
growth-enhancing mutations in the env gene (11, 12). Input viruses
obtained from transfected 293T cells were inoculated into M1.3
cells, and virus replication was periodically monitored. As shown
in Fig. 6A, 4gtu grew better than 5gtu (note the peak day for RT
production), consistent with a previous report (12). Virus growth
kinetics of 5gtu and 66SR+5gtu were similar, but virion production
levels on the peak day (day 15 post- infection) and thereafter, as
judged by RT activity, of 66SR+5gtu were lower than those of 5gtu.
We were interested in determining the efficiency of early and late
replication phases of the three HIV-1rmt clones. To this end, viral
single-cycle infectivity for TZM-bl cells (early) of progeny virions
produced from infected M1.3S cells and progeny virion level (late)
upon transfection into 293T cells were determined. Culture super-
natants were collected from infected M1.3S cells (Fig. 6A), and
equal RT units of viruses from each sampling day were inoculated
into TZM-bl cells. On day 1 post- infection, cell lysates were pre-
pared for luciferase assays. Single-cycle viral infectivity was calcu-
lated as relative luciferase activity to that of 5gtu. In Fig. 6B, rela-
tive infectivity was presented as the average of infectivity for each
day (from day 6 to 33). Viral infectivity of 4gtu and 66SR+5gtu was
higher than that of 5gtu, and 66SR+5gtu showed comparable in-
fectivity to 4gtu. We next examined virion production level of the
three HIV-1rmt clones in transfected 293T cells. In fragile ma-
caque M1.3S cells, it is very difficult to obtain constant and repro-
ducible results by transfection. As shown in Fig. 6C, while progeny
virions of 4gtu and 5gtu were at similar levels, 66SR+5gtu produced
those at a level reduced to around 40% to that of 5gtu. Gag-MA is
demonstrated to fulfill its function at various steps in the HIV-1
assembly process (1, 8, 9). It is therefore conceivable that 66SR
mutation in Gag-MA may negatively affect this stage. Collectively,
our results on the 66SR mutant virus showed that introduction of
66SR into 5gtu gives an affirmative effect on early replication phase
(single-cycle viral infectivity in Fig. 6B) but a contradictious result
on late phase (virion production level in Fig. 6C), generating simi-
lar growth kinetics in multi -cycle infection experiments (Figs. 5
and 6A). Lower virus level observed for 66SR+5gtu relative to that
for parental 5gtu (Figs. 5 and 6A) may be explained by its feeble
ability to produce progeny virions (Fig. 6C), and also, at least in
part, by its cytopathogenic property described above. Quite differ-
ent from our results, positive effects of the 66SR mutation on viral
single-cycle infectivity were not observed for HIV-1 NL4-3 clone
(10). This may be attributable to differences in gp41 CT amino acid
Figure 5 Growth kinetics in rhesus macaque M1.3S cells of various
HIV-1rmt clones. Input viruses were prepared from 293T cells transfected
with proviral clones indicated, and inoculated into M1.3S cells. For in-
fection, 2.0105 M1.3S cells were inoculated with equal viral RT units
(1.0106). Virus growth was monitored at intervals by RT activity in the
culture supernatants.
Figure 6 Replication properties of various HIV-1rmt clones. (A) Multi -
cycle replication kinetics in rhesus lymphocyte M1.3S cells. Input viruses
were prepared from 293T cells transfected with proviral clones indicated,
and inoculated into M1.3S cells. For infection, 1.0106 M1.3S cells were
inoculated with equal viral RT units (6.6105). Virus growth was moni-
tored at intervals by RT activity in the culture supernatants. (B) Viral
single -cycle infectivity. Culture supernatants obtained from the M1.3S
infection experiment in (A) were used for determination of viral infec-
tivity here. Equal RT units of virus samples from each day (from day 6
to 33 in A) were inoculated into TZM-bl cells, and on day 1 post - inocu-
lation, cell lysates were prepared for luciferase assays. Infectivity is cal-
culated as luciferase activity relative to that exhibited by 5gtu for each
sampling day. Mean values of relative infectivity obtained from samples
of day 6 to 33 are shown with the standard deviations (SD). Significance
relative to 5gtu as calculated by the Student t test is shown (***, P0.01).
(C) Virion production. Proviral clones indicated were transfected into
293T cells, and on day 2 post - transfection, progeny virus production was
measured by RT activity in the culture supernatants. RT activity relative
to that produced by 5gtu is presented. Mean valuesSD from at least
five independent experiments are shown. Significance relative to 5gtu as
calculated by the Student t test is shown (***, P0.01).
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sequences (Fig. 4). It would be plausible to assume that Gag-MA
66SR have appreciable impacts on viral clones carrying some spe-
cific Env sequences.
In conclusion, we demonstrate here that Gag-MA 66SR muta-
tion increases the single-cycle infectivity of R5-tropic HIV-1rmt
5tgu but impedes the virion production efficiency. Because muta-
tions in Gag-MA affect much the virion assembly process as de-
scribed above, this defect may be restored by combinations of the
other Gag-MA mutations previously reported (10). Improvement
of HIV-1rmt clones carrying 66SR in the virion production level
may lead to generation of new viral clones with better growth po-
tentials. In this regard, we already gained a number of growth-
enhanced viral clones by long-term cultures of virus- infected cells
(18). Adaptation of 66SR+5gtu to M1.3S cells in a similar way is in
progress. These experimental studies would provide technically
useful information to improve growth potentials of R5-tropic HIV-
1rmt clones, and contribute to the establishment of HIV-1/AIDS
primate models. Obtaining R5-tropic HIV-1rmt clones pathogenic
for rhesus macaques represents the cornerstone of AIDS models,
and may help the development of clinical approaches aimed at bet-
ter treatments of infected individuals.
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